Skip to content

Medication Understanding in MS

Home-based Assessment of Medication Understanding and Use in People With Multiple Sclerosis

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07518381
Acronym
MUMS
Enrollment
80
Registered
2026-04-08
Start date
2026-04-15
Completion date
2026-09-01
Last updated
2026-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

polypharmacy, medication use, medication understanding, medication management, multiple sclerosis, adherence, medication burden, home medication review

Brief summary

The goal of this observational study is to learn how people with multiple sclerosis (MS) understand, organise, and use their medicines at home. The study aims to explore how people take their prescribed and non-prescribed medicines, what challenges they experience, and whether any safety issues arise in day-to-day medication use. Participants will take part in one home visit with trained student researchers. During the visit, researchers will review all medicines and supplements the participant uses, ask about routines and any difficulties, check medication packaging with permission, and ask a brief question about memory. No treatment changes will be made. Information will be reviewed by a senior clinician, and any safety concerns will be shared with the participant's usual healthcare team.

Interventions

None listed

Sponsors

University of Nottingham
Lead SponsorOTHER
University Hospitals of Derby and Burton NHS Foundation Trust
CollaboratorOTHER
Nottingham University Hospitals NHS Trust
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 years and over with a confirmed diagnosis of multiple sclerosis * Living in the community (not in residential care) * Taking at least one prescribed medication * Able to provide informed consent or, for those without capacity to provide informed consent, with a consultee available to provide consultee declaration and provide information during home-based medication review * Willing and able to participate in a home-based medication review

Exclusion criteria

* Severe cognitive or communication impairment without a consultee to provide consultee declaration and medication-related information * Participants for whom a home visit is deemed unsafe * Non-English speakers

Design outcomes

Primary

MeasureTime frameDescription
Medication Burden (Descriptive)BaselineTotal number of prescribed and non-prescribed medications and supplements used by each participant, recorded during the home-based medication review. This includes dose, frequency, route, and source of each item. The outcome will be summarised descriptively (counts, means, ranges).

Secondary

MeasureTime frameDescription
Medication Adherence (MARS-5 Score)BaselineSelf-reported adherence measured using the 5-item Medication Adherence Report Scale (MARS-5). Scores range from 5 to 25, with higher scores indicating better adherence. Results will be summarised descriptively.
Medication-Related ChallengesBaselineProportion of participants reporting difficulties with medication supply, administration, formulation, or perceived effectiveness, based on structured trigger questions. Reported descriptively.
Subjective Cognitive Decline (Single-Item Question)Baseline("Yes"/"No") to the validated single-item subjective cognitive decline question ("Do you feel you have more problems with your memory than most?"). Used to contextualise medication-taking behaviours. Summarised descriptively.
Medication Organisation and Use of AidsBaselineUse of medication aids such as dosette boxes, blister packs, phone reminders, or charts. Recorded as present/absent and described using frequencies.
Medication Storage and Safety IssuesBaselineNumber and type of potential safety issues identified during the home visit, including expired medicines, duplicate supplies, unmonitored supplements, or storage concerns. Summarised descriptively.

Contacts

CONTACTLaura Edwards, FRCP PhD
laura.edwards@nottingham.ac.uk01332258238

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 9, 2026